<DOC>
	<DOC>NCT03053999</DOC>
	<brief_summary>The study aims to identify predictors of disease in patients with hyperparathyroidism (HPTH) who undergo surgery.</brief_summary>
	<brief_title>Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)</brief_title>
	<detailed_description>Researchers aim to identify somatic mutations and inherited genetic variants which may help predict the development of PNET in patients with hyperparathyroidism.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Adenoma, Islet Cell</mesh_term>
	<mesh_term>Endocrine Gland Neoplasms</mesh_term>
	<mesh_term>Multiple Endocrine Neoplasia</mesh_term>
	<criteria>1. MEN1 patients who have undergone parathyroidectomy and did not develop PNET. 2. MEN1 patients who have undergone parathyroidectomy and had surgical removal of PNET.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Multiple Endocrine Neoplasia</keyword>
	<keyword>Pancreatic Neuroendocrine Tumors</keyword>
	<keyword>Hyperparathyroidism</keyword>
	<keyword>HPTH</keyword>
	<keyword>PNET</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Parathyroidectomy</keyword>
	<keyword>Genome sequencing</keyword>
	<keyword>Data review</keyword>
</DOC>